Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Clorazepate dipotassium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for clorazepate dipotassium?

Clorazepate dipotassium is the generic ingredient in four branded drugs marketed by Quantum Pharmics, Recordati Rare, Mylan, Sun Pharm Inds Ltd, Aurolife Pharma Llc, Lederle, Purepac Pharm, Gd Searle Llc, Warner Chilcott, Am Therap, Taro, Dava Pharms Inc, Usl Pharma, Watson Labs, Able, and Alra, and is included in sixty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for clorazepate dipotassium. Eleven suppliers are listed for this compound.

Summary for Generic Name: clorazepate dipotassium

Tradenames:4
Patents:1
Applicants:16
NDAs:64
Drug Master File Entries: see list8
Suppliers / Packagers: see list11
Bulk Api Vendors: see list24
Patent Applications: see list439
Drug Prices:see low prices
DailyMed Link:clorazepate dipotassium at DailyMed

Pharmacology for Ingredient: clorazepate dipotassium

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL072332-001Aug 8, 1988DISCNNoNo► Subscribe► Subscribe
Lederle
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL072014-001Dec 15, 1987DISCNNoNo► Subscribe► Subscribe
Watson Labs
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL071853-001Feb 9, 1988DISCNNoNo► Subscribe► Subscribe
Dava Pharms Inc
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
CAPSULE;ORAL071743-001Dec 14, 1987DISCNNoNo► Subscribe► Subscribe
Aurolife Pharma Llc
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL072512-001May 11, 1990DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: clorazepate dipotassium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-008Approved Prior to Jan 1, 1982RE28315► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-001Approved Prior to Jan 1, 1982RE28315► Subscribe
Recordati Rare
TRANXENE SD
clorazepate dipotassium
TABLET;ORAL017105-005Approved Prior to Jan 1, 1982RE28315► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-006Approved Prior to Jan 1, 1982RE28315► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-007Approved Prior to Jan 1, 1982RE28315► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc